Patrinia scabiosaefolia L. Modulates the Intestinal Microecology to Treat DSS-Induced Ulcerative Colitis: UHPLC-OE-MS/MS, Network Pharmacology, and Experimental Validation
Open Access
Abstract
Patrinia scabiosaefolia L. (P. scabiosaefolia), a traditional food and medicinal plant, is used to treat internal inflammation. This study investigated the mechanisms by which P. scabiosaefolia improves ulcerative colitis (UC) via combined UHPLC-OE-MS/MS, network pharmacology, molecular docking, and animal experiments. A total of 72 compounds were detected in the P. scabiosaefolia extraction, with 15 key components (ranking by degree value) selected for further analysis. GO enrichment analysis suggested that PS may alleviate UC-related renal dysfunction by modulating immune responses, inflammation, and cell signaling pathways. Based on protein–protein interaction results, five core targets of P. scabiosaefolia in UC (ranking by degree value) were identified, and molecular docking revealed strong binding free affinity (<−7 kcal/mol) of active components (Vulgarin and 4-(Diphenylphosphino)benzoic acid) with TNF, AKT1, CASP3, BCL2, and MMP9. In animal experiments, P. scabiosaefolia-treated mice showed significant reductions in IL-6, TNF-α, LPS, and D-Lactate levels (p < 0.05); improved colon histopathological damage; and significantly increased the mRNA expression of tight junction proteins (ZO-1, Claudin, OCC) in colon tissue (p < 0.05). Furthermore, P. scabiosaefolia-treated mice exhibited a significant increase in beneficial gut bacteria (Enterococcus and Lactobacillus) (p < 0.05), effectively restoring the gut imbalance caused by DSS. In conclusion, P. scabiosaefolia can treat UC through the modulation of the intestinal microecology.Keywords
Funding Information
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX22 3500, KSUZDSYS202305)
- Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry in Kashi University (KYCX22 3500, KSUZDSYS202305)
This publication has 24 references indexed in Scilit:
- Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptomsJournal of Functional Foods, 2025
- In vitro gastrointestinal digestion and colonic fermentation of Mangiferin: Impacts on gut microbiota and metabolite profilesJournal of Functional Foods, 2025
- Chlorella pyrenoidosa ameliorates ulcerative colitis by tuning intestinal microecology: Butyric acid is a crucial playerJournal of Functional Foods, 2024
- Corrigendum to “The traditional herb Sargentodoxa cuneata alleviates DSS-induced colitis by attenuating epithelial barrier damage via blocking necroptotic signaling” [J. Ethnopharmacol. 319P3 (2024) 117373]Journal of Ethnopharmacology, 2024
- Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathwayJournal of Ethnopharmacology, 2023
- Potential associations between organic dairy products, gut microbiome, and gut health: A reviewFood Research International, 2023
- New iridoids from Patrinia scabiosaefolia and their hypoglycemic effects by activating PI3K/Akt signaling pathwayFitoterapia, 2023
- The Herba Patriniae (Caprifoliaceae): A review on traditional uses, phytochemistry, pharmacology and quality controlJournal of Ethnopharmacology, 2021
- Identification of anti-inflammatory constituents from Kalimeris indica with UHPLC-ESI-Q-TOF-MS/MS and GC–MSJournal of Ethnopharmacology, 2015
- The tight junction in inflammatory disease: communication breakdownCurrent Opinion in Pharmacology, 2009